Pettitt, Andrew R. 2009. “The Role of Alemtuzumab in Chronic Lymphocytic Leukaemia Patients With p53 Defects”. Hematology Meeting Reports (formerly Haematologica Reports) 1 (5). https://doi.org/10.4081/hmr.v1i5.638.